The goal is to provide the highest quality therapeutic pharmaceutical products that resolve issues for the aforementioned patients, physicians, and intuitions. This is accomplished by adhering to extensive and continuous quality control and assurance programs, focusing on and in strict compliance with Current Good Manufacturing Processes (CGMP) and U.S. Pharmacopeia Guidelines (USP) and regulations. In addition, our firm complies with all applicable federal, state, and local statutes and regulations in effect and maintains a high level of consistency, efficiency, and quality in each our medications.
The firm was established in 2015, and has developed and maintained a successful reputation and history, constantly committed to exceeding current manufacturing standards. Our cutting edge technology is evidenced by our quality assurance program, and our committment to precision and personalized medicine.
Synergistic Therapeutics, LLC has embraced the philosophy of developing products based on the principle of “high patient demand and limited available products”. We believe that a diversified product line is of a greater value than limited product lines. Depression affects 60-70 million people in the U.S. with over 25% of these cases involving Major Depressive Disorder (MDD) or Treatment Resident Depression (TRD). Hair loss affects approximately 35 million men and 21 million women in the U.S.. Neuropathic pain and chronic pain affect between 10-35% of the U.S. population. Female sexual dysfunction affects over 10 million premenopausal women in the U.S.
Other revolutionary medications in research and development consist treatments for Postpartum Depression, Post Traumatic Stress Disorder, Addiction, and Bipolar Disorder.